A
Alexander I. Gray
Researcher at Strathclyde Institute of Pharmacy and Biomedical Sciences
Publications - 296
Citations - 7233
Alexander I. Gray is an academic researcher from Strathclyde Institute of Pharmacy and Biomedical Sciences. The author has contributed to research in topics: Eriostemon & Premna. The author has an hindex of 41, co-authored 292 publications receiving 6648 citations. Previous affiliations of Alexander I. Gray include University of Strathclyde & Netaji Subhas Institute of Technology.
Papers
More filters
Journal ArticleDOI
Coumarins from Phebalium tuberculosum ssp. megaphyllum and Phebalium filifolium.
TL;DR: Three of the coumarins obtained from P. tuberculosum ssp.
Journal ArticleDOI
Coumarins from the seeds of Angelica sylvestris (Apiaceae) and their distribution within the genus Angelica
E. Murphy,Lutfun Nahar,Maureen Byres,Mohammad Shoeb,Munachonga Siakalima,M. Mukhlesur Rahman,Alexander I. Gray,Satyajit D. Sarker +7 more
Journal ArticleDOI
Tetra− and pentacyclic 6-c-monoterpenyl-5,7-dioxycoumarins from Eriostemon brucei and e. Brucei subspecies cinereus
TL;DR: An investigation of the aerial parts of Eriostemon brucei and E. cinereus revealed the presence of the coumarins eriobrucinol and 5′β-hydroxyeriobruinol and five further 6- C -monoterpenyl-5,7-dioxycoumarins which are reported as natural products for the first time.
Journal ArticleDOI
In vitro anti-diabetic effect of flavonoids and pheophytins from Allophylus cominia Sw. on the glucose uptake assays by HepG2, L6, 3T3-L1 and fat accumulation in 3T3-L1 adipocytes
TL;DR: Allophylus cominia is potentially a new candidate for the treatment and management of T2-DM and the pharmacological effects of the extracts from A. cominia observed in experimental diabetic models were shown.
Journal ArticleDOI
In vitro anti-diabetic activity of flavonoids and pheophytins from Allophylus cominia Sw . on PTP1B, DPPIV, alpha-glucosidase and alpha-amylase enzymes
TL;DR: The pharmacological effects of the extracts from Allophylus cominia earlier observed in experimental diabetic models was confirmed and a new drug or formulation for the treatment of T2-DM could be developed from A. cominia.